AUPH Competitors & Alternatives
Compare Aurinia Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
AUPH
Main Stock$14.57
Tradestie Score
56
Market Cap
$1.50B
P/E Ratio
6.9
Revenue Growth
0.2%
Analyst Upside
+16.7%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$15.88
|
$2.02B | 42.5 | 49 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$10.77
|
$2.01B | - | 50 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$38.86
|
$1.97B | - | 57 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$8.40
|
$1.92B | - | 58 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$87.72
|
$1.92B | - | 45 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$83.85
|
$1.90B | 494.8 | 56 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$32.23
|
$1.84B | - | 47 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.43
|
$1.81B | - | 51 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.83
|
$1.78B | - | 55 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$25.24
|
$1.78B | - | 55 | Compare |
More AUPH Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry